Effectiveness of Laying-on-of-hands for Sickle Cell Disease

Effectiveness of Laying-on-of-hands for Patients With Sickle Cell Disease in Africa

Status

Completed

Phases

Phase 2

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01518218

Enrollment

Registered

2012-01-25

Start date

2006-03-31

Completion date

2009-12-31

Last updated

2015-04-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anemia, Death, Infection, Pain Crisis Recurrent, Sickle Cell Disease

Keywords

Sickle cell disease, laying-on-of-hands, morbidity, mortality

Brief summary

The objective of this study is to evaluate the effectiveness of 1-year administration of laying-on-of-hands on the morbidity and mortality of patients with sickle cell disease in Africa.

Detailed description

Patients with sickle cell disease (SCD) have a high risk of premature death in Africa, mainly due to insufficient medical services. SCD patients often visit emergency department and need hospitalization when they suffer from severe pain; however, they manage most of painful episodes at home. Appropriate pain management at home is, therefore, crucial to improve their clinical course and quality of life. Laying-on-of-hands may be a good candidate for home care management, because family member(s) can become a practitioner of laying-on-of-hands without difficulty and administer it to their loved one as an initial treatment whenever necessary. There are no reports concerning the effectiveness of laying-on-of-hands for the outcomes of SCD patients, as far as we have investigated.

Interventions

BEHAVIORALlaying-on-of-hands

The intervention group received laying-on-of-hands every weekday for 1 year along with conventional medicine. The control group did not undergo any alternatives to OPT.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

3 Years to 40 Years

Healthy volunteers

Inclusion criteria

* patients with symptoms associated with sickle cell disease * those able to receive laying-on-of-hands every weekday for 1 year * those able to receive conventional medical treatment whenever necessary * those able to receive blood test at the beginning, after 6 month and after 1 year

Exclusion criteria

* those who wish to use other complementary and alternative therapies along with laying-on-of-hands

Design outcomes

Primary

Measure	Time frame
disease-related episodes and mortality	3 years and 9 months

Secondary

Measure	Time frame
blood data	1 year

Countries

Democratic Republic of the Congo

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026